PPARβ/δ priming enhances mesenchymal stromal cell anti-apoptotic properties on chondrocytes via ANGPTL4 and improves their therapeutic effects in osteoarthritis
Stem Cells Translational Medicine · 20.07.2026 · 15 (8)
DOI: 10.1093/stcltm/szag053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 05.08.2026. Verfasst von Claudia Terraza-Aguirre und 14 weiteren Autor:innen. Beteiligte Einrichtung: IRMB, Université de Montpellier, INSERM, Montpellier, 34295, France. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Apoptosis, Chondrocytes, Angiopoietin-Like Protein 4. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut national de la santé et de la recherche médicale, French National Research Agency, Association Nationale de la Recherche et de la Technologie (ANRT) and CellVax SAS.
Abstract (Originalsprache)
Background
Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage degradation, chondrocyte apoptosis, and inflammation. Mesenchymal stromal cells (MSCs) offer therapeutic potential, but their efficacy is hindered by oxidative stress and functional heterogeneity. We investigated whether PPARβ/δ priming enhances MSC therapeutic properties and explored the underlying mechanisms.
Methods
MSCs were primed with the PPARβ/δ agonist GW501516. In a collagenase-induced OA mouse model, we assessed cartilage integrity by confocal laser scanning microscopy and histological grading. In vitro, we evaluated the effects of primed MSCs on oxidative stress resistance, chondrocyte apoptosis, and immunomodulation using DNA fragmentation, co-culture assays, and RNA sequencing.
Results
PPARβ/δ priming significantly enhanced MSC resistance to oxidative stress, preserving their survival under H2O2-induced conditions. In co-culture experiments, primed MSCs exhibited a superior chondroprotective effect, reducing apoptosis in stressed chondrocytes. In vivo, primed MSCs improved cartilage volume, thickness, and integrity, lowering OA severity scores. RNA sequencing identified ANGPTL4 as a key mediator of these effects, as its silencing abolished MSC-mediated chondroprotection.
Conclusion
PPARβ/δ priming enhances the therapeutic potential of MSCs by increasing their resistance to oxidative stress and anti-apoptotic effects on chondrocytes, mediated by ANGPTL4. These findings suggest a promising strategy for optimizing MSC-based therapies for OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRMB, Université de Montpellier, INSERM, Montpellier, 34295, France.
- CellVax, SAS, Villejuif, 94800, France.
- Nantes Université, Oniris, CHU Nantes, Inserm, Regenerative Medicine and Skeleton RMeS, UMR1229, Nantes F-44000, France.
- IGF, Université de Montpellier, CNRS, INSERM, Montpellier, 34094, France.
- Clinical Immunology and Osteoarticular Disease Therapeutic Unit, Department of Rheumatology, CHU Montpellier, Montpellier, 34095, France.
ORCID-Profile: Stéphanie Barrère-Lemaire, Farida Djouad
Förderung
- Institut national de la santé et de la recherche médicale
- French National Research Agency
- Association Nationale de la Recherche et de la Technologie (ANRT) and CellVax SAS
Zitieren
APA
Terraza-Aguirre, C., Contreras-López, R., Bernard, C., Pradenas, C., De la Cruz, J., Barthelaix, A., Asencio, C., Tejedor, G., Boyer, C., Barrère-Lemaire, S., Jorgensen, C., Wei, M., Guicheux, J., Vinatier, C., & Djouad, F. (2026). PPARβ/δ priming enhances mesenchymal stromal cell anti-apoptotic properties on chondrocytes via ANGPTL4 and improves their therapeutic effects in osteoarthritis. Stem Cells Translational Medicine, 15(8). https://doi.org/10.1093/stcltm/szag053
Vancouver
Terraza-Aguirre C, Contreras-López R, Bernard C, Pradenas C, De la Cruz J, Barthelaix A, et al. PPARβ/δ priming enhances mesenchymal stromal cell anti-apoptotic properties on chondrocytes via ANGPTL4 and improves their therapeutic effects in osteoarthritis. Stem Cells Translational Medicine. 2026;15(8). doi:10.1093/stcltm/szag053
BibTeX
@article{TerrazaAguirre2026,
author = {Terraza-Aguirre, Claudia and Contreras-López, Rafael and Bernard, Clara and Pradenas, Carolina and De la Cruz, Jholy and Barthelaix, Audrey and Asencio, Catalina and Tejedor, Gautier and Boyer, Cécile and Barrère-Lemaire, Stéphanie and Jorgensen, Christian and Wei, Mingxing and Guicheux, Jerome and Vinatier, Claire and Djouad, Farida},
title = {PPARβ/δ priming enhances mesenchymal stromal cell anti-apoptotic properties on chondrocytes via ANGPTL4 and improves their therapeutic effects in osteoarthritis},
journal = {Stem Cells Translational Medicine},
year = {2026},
volume = {15},
number = {8},
doi = {10.1093/stcltm/szag053}
}
EUVIMED